Literature DB >> 31347509

Audiological and Vestibular Findings in Subjects with MELAS Syndrome.

Dan Dupont Hougaard1, Danial Hofgaard Hestoy2, Allan Thomas Hojland3, Michael Gailhede1, Michael Bjorn Petersen4.   

Abstract

OBJECTIVES: The mitochondrial DNA (mtDNA) point mutation m.3243A>G is known to express the following two syndromes among others: maternally inherited diabetes and deafness (MIDD) and mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Sensorineural hearing loss (SNHL) is the most frequent symptom in individuals harboring the m.3243A>G mutation. However, dysfunction of the vestibular organs has been scarcely examined. Therefore, the present study aimed to study the impact of the m.3243A>G mutation on the inner ear.
MATERIALS AND METHODS: A total of 8 subjects harboring the blood-verified m.3243A>G mutation underwent thorough audiological and vestibular examinations, including tone and speech audiometry, video head impulse test (vHIT), ocular and cervical vestibular-evoked myogenic potential (oVEMP and cVEMP), and full otoneurological examination. The subjects also answered a Dizziness Handicap Inventory (DHI) questionnaire.
RESULTS: SNHL was identified in all the 8 subjects, with a mean pure-tone average-4 (PTA-4) of 59 dB. Speech discrimination score (n=7) ranged from 24% to 100% (mean 74%), and vHIT (n=42) detected pathology in nine lateral semicircular canals (SCCs), five posterior SCCs, and one anterior SCC, whereas three measurements were inconclusive. All oVEMPs (n=14 ears) were absent, nine cVEMPs were absent, and two were inconclusive. Based on the DHI scores, 6 subjects reported none to mild dizziness, 1 reported moderate, and 1 reported severe dizziness.
CONCLUSION: Our study population had pathological findings from every audiological and vestibular end organs. The results indicated that the pathological findings originated from within the end organs themselves and not within the superior and inferior vestibular or cochlear nerve.

Entities:  

Mesh:

Year:  2019        PMID: 31347509      PMCID: PMC6750775          DOI: 10.5152/iao.2019.5913

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  26 in total

1.  Galvanic-evoked myogenic responses in patients with an absence of click-evoked vestibulo-collic reflexes.

Authors:  Toshihisa Murofushi; Hideki Takegoshi; Masafumi Ohki; Hidenori Ozeki
Journal:  Clin Neurophysiol       Date:  2002-02       Impact factor: 3.708

2.  The epidemiology of pathogenic mitochondrial DNA mutations.

Authors:  P F Chinnery; M A Johnson; T M Wardell; R Singh-Kler; C Hayes; D T Brown; R W Taylor; L A Bindoff; D M Turnbull
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

3.  Galvanic stimulation evokes short-latency EMG responses in sternocleidomastoid which are abolished by selective vestibular nerve section.

Authors:  S R Watson; P Fagan; J G Colebatch
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1998-12

4.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

5.  Cervical and ocular vestibular-evoked myogenic potentials in acute vestibular neuritis.

Authors:  Byoung-Soo Shin; Sun-Young Oh; Ji Soo Kim; Tae-Woo Kim; Man-Wook Seo; Hyung Lee; Young-Ae Park
Journal:  Clin Neurophysiol       Date:  2011-07-19       Impact factor: 3.708

6.  Progressive sensorineural hearing impairment in maternally inherited diabetes mellitus and deafness (MIDD).

Authors:  Jan-Jaap Hendrickx; Aart H Mudde; Leen M 't Hart; Patrick L M Huygen; Cor W R J Cremers
Journal:  Otol Neurotol       Date:  2006-09       Impact factor: 2.311

7.  The mitochondrial A3243G mutation involves the peripheral vestibule as well as the cochlea.

Authors:  Shinichi Iwasaki; Naoya Egami; Chisato Fujimoto; Yasuhiro Chihara; Munetaka Ushio; Akinori Kashio; Tatsuya Yamasoba
Journal:  Laryngoscope       Date:  2011-08       Impact factor: 3.325

8.  Population prevalence of the MELAS A3243G mutation.

Authors:  Neil Manwaring; Michael M Jones; Jie Jin Wang; Elena Rochtchina; Chris Howard; Paul Mitchell; Carolyn M Sue
Journal:  Mitochondrion       Date:  2007-01-08       Impact factor: 4.160

9.  Test-retest reliability and age-related characteristics of the ocular and cervical vestibular evoked myogenic potential tests.

Authors:  Kimanh D Nguyen; Miriam S Welgampola; John P Carey
Journal:  Otol Neurotol       Date:  2010-07       Impact factor: 2.311

Review 10.  Characteristics and clinical applications of vestibular-evoked myogenic potentials.

Authors:  Miriam S Welgampola; James G Colebatch
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

View more
  3 in total

1.  Endocrine Manifestations and New Developments in Mitochondrial Disease.

Authors:  Yi Shiau Ng; Albert Zishen Lim; Grigorios Panagiotou; Doug M Turnbull; Mark Walker
Journal:  Endocr Rev       Date:  2022-05-12       Impact factor: 25.261

2.  Cochlear Implantation in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome: Case Presentation.

Authors:  Gemma Crundwell; Peter Kullar; Manohar Bance
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

3.  Rare Phenotypic Manifestations of MELAS.

Authors:  Josef Finsterer
Journal:  Yonsei Med J       Date:  2020-10       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.